The approval of Afrezza has catapulted the company's shares, but don't get suckered into chasing it.
The stock falls 15% after the company's obesity drug, thought to be a game-changer, suffers a setback.
Companies in diabetes treatment, weight management and weight-loss drugs could see see huge growth.
Siemens is upgraded to 'outperform,' and Accretive Health is downgraded to 'neutral.'
Sprint is reinstated with an 'underperform,' Michael Kors is downgraded to 'neutral.'
Cree is downgraded to 'neutral,' and Zale is initiated with an 'overweight.'
After the Dow and the S&P 500 closed at all time highs, US markets are set to open unchanged.
VIDEO ON MSN MONEY
Copyright © 2014 Microsoft. All rights reserved.
The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.
MONEY & POLITICS
Breaking up big banks is an untested solution to the too big to fail problem that attempts to isolate and dismantle large, troubled institutions while protecting the rest of the economy.
Your health may improve if you cut gluten out of your diet, but your pocketbook will take a hit -- unless you follow these tips.
Six weeks later, most Americans have forgotten about the 2014 tax season -- except those who didn't file by the April 15 deadline.
MUST-SEE ON MSN
- Video: Easy DIY smoked meats at home
A charcuterie master shares his process for cold-smoking meat at home.
- Jetpacks about to go mainstream
- Weird things covered by home insurance
- Bing: 70 percent of adults report 'digital eye strain'